June 30, 2017
The European court of human rights has rejected an appeal by the parents of a critically ill baby that he should be allowed to undergo experimental treatment in the US.
The decision by the Strasbourg court closes off the last legal avenue of appeal for the family of Charlie Gard and follows a similar ruling by the UK’s supreme court.
The judgment also lifts a court order under which doctors at Great Ormond Street hospital in London had been required to maintain life support treatment for the 10-month-old child who has brain damage and a rare genetic condition.
The hospital said it would not “rush …. to change Charlie’s care” and that any alteration to his current treatment would “involve careful planning and discussion”.
In a statement, the ECHR said it had, by a majority of the seven judges who considered the written arguments, declared the application inadmissible. It “endorsed in substance the approach” taken by the British courts and declared “the decision is final”.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.